U. DEMİRSOY Et Al. , "Results of vincristine, cyclophosphamide, and topotecan protocol in refractory/relapsed pediatric solid tumors: A single-center experience.," Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer , vol.33, Illinois, United States Of America, 2015
DEMİRSOY, U. Et Al. 2015. Results of vincristine, cyclophosphamide, and topotecan protocol in refractory/relapsed pediatric solid tumors: A single-center experience.. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer , (Illinois, United States Of America).
DEMİRSOY, U., Corapcioglu, F., Karadogan, M., Gungormus, A., & Ozod, U., (2015). Results of vincristine, cyclophosphamide, and topotecan protocol in refractory/relapsed pediatric solid tumors: A single-center experience. . Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America
DEMİRSOY, UĞUR Et Al. "Results of vincristine, cyclophosphamide, and topotecan protocol in refractory/relapsed pediatric solid tumors: A single-center experience.," Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 2015
DEMİRSOY, UĞUR Et Al. "Results of vincristine, cyclophosphamide, and topotecan protocol in refractory/relapsed pediatric solid tumors: A single-center experience.." Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer , Illinois, United States Of America, 2015
DEMİRSOY, U. Et Al. (2015) . "Results of vincristine, cyclophosphamide, and topotecan protocol in refractory/relapsed pediatric solid tumors: A single-center experience.." Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer , Illinois, United States Of America.
@conferencepaper{conferencepaper, author={UĞUR DEMİRSOY Et Al. }, title={Results of vincristine, cyclophosphamide, and topotecan protocol in refractory/relapsed pediatric solid tumors: A single-center experience.}, congress name={Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer}, city={Illinois}, country={United States Of America}, year={2015}}